Page last updated: 2024-12-05

2,3-diaminopyridine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,3-Diaminopyridine is a heterocyclic compound with two amino groups attached to the pyridine ring at positions 2 and 3. It is a white to off-white solid that is soluble in water and organic solvents. The compound has been investigated for its potential as a precursor to various pharmaceuticals and as a ligand in coordination chemistry. Its synthesis is typically achieved through the reduction of 2,3-dinitropyridine using various reducing agents. 2,3-Diaminopyridine has been explored for its pharmacological effects, including its potential as an anti-inflammatory agent. Its importance lies in its ability to act as a building block for more complex molecules with potential therapeutic applications. The compound is studied for its potential to interact with metal ions, forming coordination complexes with unique properties. This aspect is explored in the field of coordination chemistry.'

diaminopyridine : Compounds containing a pyridine skeleton substituted by two amino groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9956
CHEBI ID195591
SCHEMBL ID88338
SCHEMBL ID3952094
MeSH IDM0116139

Synonyms (56)

Synonym
AC-3570
BB 0260604
diaminopyridine
2,3-diaminopyridine ,
nsc-45406
pyridine,3-diamino-
nsc45406
2,3-pyridinediamine
452-58-4
AC-907/25014077
pyridine-2,3-diamine
pyridine, 2,3-diamino-
einecs 207-200-9
pyridine-2,3-diyldiamine
nsc 45406
brn 0109869
ai3-52327
2,3-diaminopyridine, 95%
D0117
AKOS005135856
STK802242
CHEBI:195591
2,3-diaminopyridine
A7127
EN300-56505
BBL011063
unii-cbx394737h
cbx394737h ,
5-22-11-00241 (beilstein handbook reference)
BP-12738
FT-0602123
AM20070113
SCHEMBL88338
2,3 diamino pyridine
2,3-diamino-pyridine
SCHEMBL3952094
BG-0085
dtxsid0051493 ,
NCGC00357096-01
dtxcid9030676
tox21_303818
cas-452-58-4
W-106156
STR01839
mfcd00006319
F0001-1225
2,3-diaminopyridine, vetec(tm) reagent grade, 94%
76x ,
CS-D1498
2,3-diamino pyridine
BCP04951
benzenepropanoic acid, 4-chloro-.beta.-oxo-, ethyl ester
CCG-302490
Q27275394
SB75564
Z385438806
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aminopyridineCompounds containing a pyridine skeleton substituted by one or more amine groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency63.26090.002541.796015,848.9004AID1347395
GLI family zinc finger 3Homo sapiens (human)Potency8.86490.000714.592883.7951AID1259369; AID1259392
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency30.63790.001022.650876.6163AID1224838; AID1224893
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency27.30600.001530.607315,848.9004AID1224841
pregnane X nuclear receptorHomo sapiens (human)Potency61.13060.005428.02631,258.9301AID1346982
thyroid stimulating hormone receptorHomo sapiens (human)Potency76.95880.001628.015177.1139AID1259385
Histone H2A.xCricetulus griseus (Chinese hamster)Potency126.79300.039147.5451146.8240AID1224845
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (11.76)18.7374
1990's2 (11.76)18.2507
2000's9 (52.94)29.6817
2010's4 (23.53)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.13 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.91 (4.65)
Search Engine Demand Index36.32 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]